Symposium: ​​6th Virtual Bio-Techne Targeted Protein Degradation and Induced Proximity Symposium​

The 6th Virtual Bio-Techne Targeted Protein Degradation and Induced Proximity Symposium brings together cutting-edge research from leading scientists across academia and industry. This year’s talks span emerging approaches to rewiring the cell surface proteome, live-cell protein analysis and induced proximity using a novel self-labelling tag platform, and new strategies for targeting extracellular disease proteins. Additional sessions explore an industry perspective on DMPK optimization for PROTAC® Degraders and the development of bifunctional Degraders and Acetylation Targeting Chimera (AceTAC) technologies for cancer therapy. This free, virtual event is open to all and offers a unique opportunity to stay at the forefront of this rapidly evolving field.

Speakers

Rewiring the Cell Surface Proteome through Trogocytosis Nick Till NIH Postdoctoral Fellow (Bertozzi Lab), Stanford University

BromoCatch: a self-labelling tag platform for induced proximity applications and live cell imaging Maria Rodriguez-Rios Postdoctoral Research Assistant, University of Dundee

Sortilin-based lysosome targeting chimeras (SORTACs) for degradation of extracellular disease proteins Simon Glerup Chief Scientific Officer, Draupnir Bio

DMPK optimization strategies for PROTACs Heide Duevel Scientific Associate Director DMPK, Merck

Development of Novel Bifunctional PROTAC and AceTAC Technology for the Treatment of Cancer MD Kabir Posdoctoral Fellow, Mount Sinai Center for Therapeutics Discovery

PROTAC^® is a registered trademark of Arvinas Operations, Inc., and is used under license.